purchase essay papers , high involvement purchase essay, purchase essay online , computer purchase essay
Monday, August 26, 2019
Summary and implications Essay Example | Topics and Well Written Essays - 500 words
Summary and implications - Essay Example Expected sales for Eliquis for 2012 is projected to reach $395 million (Loftus , par 2). Because of the delay in the decision of the FDA, Bristol-Myers and Pfizer might experience a decline in their sales projections which might also affect its stock prices which have gone up in the past few days at the New York Stock Exchange. The FDA justified their move by stating that the additional data submitted needs more time to review (Loftus , par 6). The original date for the decision should have been March 28 (Loftus , par 11). Boehringer Ingelheim GmbH and Johnson & Johnson, other manufacturers of new anticlotting drugs, may consider this a favorable development because it gives them time to establish their products in the market while the competition is not yet there. This means that the company may have to adjust their sales projections because it will mean a decline in their projected sales. If the launch of the product will be delayed by three months, it means that whatever projected sales for those three months will not be realized. The delay in the decision on Eliquis is good news for Boehringer Ingelheim GmbH and Johnson & Johnson. They can launch a more aggressive marketing strategy for their anticlotting drugs so that when the time comes that the FDA approves Eliquis, they have already saturated the market and may have gained loyal customers already. For the pharmaceutical industry, this should be perceived as a caveat in submitting drugs for approval of the FDA. They should make sure that all data that they submit are complete so that there will be no need for amendments later on. It will also serve as a warning to other pharmaceutical companies who intend to manufacture new anticlotting drugs that the FDA is very much concerned about bleeding risks for all patient types. In oneââ¬â¢s opinion, the move of the FDA to delay the decision on Eliquis is good because it shows that it is concerned about the effects of the drug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.